Literature DB >> 8533292

Influence of flumequine on in vivo mitogen responses of European eel (Anguilla anguilla L., 1758) lymphoid cells.

M H van der Heijden1, G H Booms, M W Tanck, J H Rombout, J H Boon.   

Abstract

The influence of flumequine on mitogen induced lymphoid cell proliferation in European eels (Anguilla anguilla L., 1758) was studied. For this purpose an in vivo test, using peroral drug administration followed by successive intraperitoneal injections with concanavalin A (ConA) or bacterial lipopolysaccharides (LPS) and 5-bromo-2'-deoxyuridine, was applied. Direct counting of proliferated cells in blood smears revealed that flumequine possesses mitogenic properties. A synergistic and an antagonistic effect of the drug was observed after LPS and ConA stimulation, respectively. Flow cytometric analysis of peripheral blood lymphoid cells showed a significant reduction of the mean proportion surface immunoglobulin positive cells in the flumequine-treated animals. It is concluded that flumequine enhances proliferation of lymphoid cells (probably surface immunoglobulin negative cells) in eel under the present experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8533292     DOI: 10.1016/0165-2427(94)05397-b

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  3 in total

1.  Hematological parameters associated with parasitism in pike, Esox lucius caught from Anzali wetland.

Authors:  Farzin Jamalzad Fallah; Hossein Khara; Javad Daghigh Rohi; Mohammad Sayadborani
Journal:  J Parasit Dis       Date:  2013-06-20

2.  Impact of antibiotic treatments on the expression of the R plasmid tra genes and on the host innate immune activity during pRAS1 bearing Aeromonas hydrophila infection in zebrafish (Danio rerio).

Authors:  Leon Cantas; Paul J Midtlyng; Henning Sørum
Journal:  BMC Microbiol       Date:  2012-03-19       Impact factor: 3.605

3.  Toxicological Evaluation of Flumequine in Pubertal Male Rats After Oral Administration for Six Weeks.

Authors:  JeongWoo Kang; Md Akil Hossain; Byungkook Choi; Joon-Hyoung Cho; Seok-Jin Kang; Hyun-Ok Ku; Sang-Hee Jeong; Hwan-Goo Kang
Journal:  J Vet Res       Date:  2018-03-30       Impact factor: 1.744

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.